Drug profile · INN
tetracycline hydrochloride
TETRACYN
tetracycline hydrochloride (TETRACYN) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — tetracycline hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
tetracycline hydrochloride (TETRACYN) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tetracycline hydrochloride?
tetracycline hydrochloride (TETRACYN) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for tetracycline hydrochloride?
TETRACYN is a marketed brand name for tetracycline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tetracycline hydrochloride?
tetracycline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.